Eden Research (LON:EDEN) Trading Down 0.2% – Here’s What Happened

Shares of Eden Research plc (LON:EDEN) traded down 0.2% during mid-day trading on Friday . The stock traded as low as GBX 3.59 ($0.05) and last traded at GBX 3.59 ($0.05). 10,000 shares were traded during mid-day trading, a decline of 99% from the average session volume of 920,772 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The company has a market capitalization of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The firm has a fifty day moving average price of GBX 3.87 and a 200-day moving average price of GBX 3.95.

Insider Activity

In other news, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek acquired 256,000 shares of Eden Research stock in a transaction on Thursday, February 6th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). 14.02% of the stock is currently owned by corporate insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.